研究者業績

八代 嘉美

ヤシロ ヨシミ  (Yoshimi Yashiro)

基本情報

所属
藤田医科大学 橋渡し研究支援人材統合教育・育成センター 教授
慶應義塾大学 殿町先端研究教育連携スクエア 再生医療リサーチセンター 特任教授
(兼任)医学部 整形外科学教室 訪問教授
厚生労働省 国立医薬品食品衛生研究所 再生・細胞医療療製品部 客員研究員
学位
博士(医学)(東京大学)
修士(医科学)(東京大学)

J-GLOBAL ID
200901022997838671
researchmap会員ID
6000016299

1976年名古屋市生まれ。2003年名城大学薬学部薬学科卒。同年東京大学大学院医学系研究科進学(指導教官:東京大学医科学研究所中内啓光教授)。在学中は造血幹細胞の遺伝子プロファイリングや老化制御機構の研究を行う。2009年博士(医学)。大学院卒業後は慶應義塾大学医学部生理学教室で特任助教を勤め、この頃から科学技術社会論的研究を開始し、幹細胞研究および再生医療に関する社会受容の形成、およびSFなどのサブカルチャー分野における生命科学の描かれ方に関する研究を行う。2011年~2012年東京女子医科大学先端生命医科学研究所特任講師、2012年慶應義塾大学医学部総合医科学研究センター特任准教授、2013年京都大学iPS細胞研究所上廣倫理研究部門特定准教授、2018年神奈川県立保健福祉大学ヘルスイノベーションスクール設置準備担当教授を経て現職。

細胞の不均一性に着目し、薬効薬理の中核となる細胞の探索や適切な原料細胞の選定、品質特性に関する研究、またそれらに関するコストなどの研究を通じて、再生医療や先端医療の社会実装の加速を目指しています。またSFやマンガなどのサブカルチャーを通して先端生命科学の受容に関する研究も行っています。これらの知見を活かした社会と再生医療の接点構築の実践をおこなうことで、再生医療が社会と協働しながら実現化していく時代を目指して指しています。


論文

 22
  • Yukitaka Kiya, Saori Watanabe, Kana Harada, Hideki Yui, Yoshimi Yashiro, Kaori Muto
    Regenerative Therapy 26 831-836 2024年6月  
  • Hideki Yui, Yoshimi Yashiro, Kaori Muto, Saori Watanabe, Yukitaka Kiya, Yusuke Inoue, Zentaro Yamagata
    Regenerative Therapy 26 9-13 2024年6月  査読有り
  • Yui H, Kamisato A, Muto K, Yashiro Y, Watanabe S, Kiya Y, Fujisawa K, Inoue Y, Yamagata Z
    Regenerative Therapy (24) 78-84 2023年12月  査読有り
  • Hideki Yui, Kaori Muto, Yoshimi Yashiro, Saori Watanabe, Yukitaka Kiya, Kumiko Fujisawa, Kana Harada, Yusuke Inoue, Zentaro Yamagata
    Stem Cell Reports 18(4) 799-806 2023年3月  査読有り
  • Hideki Yui, Kaori Muto, Yoshimi Yashiro, Saori Watanabe, Yukitaka Kiya, Ayako Kamisato, Yusuke Inoue, Zentaro Yamagata
    Regenerative Therapy 21 46-51 2022年12月  
  • Ryuma Shineha, Yusuke Inoue, Yoshimi Yashiro
    Regenerative therapy 20 187-193 2022年6月  
    Introduction: Breakthroughs in stem cell research (SCR) and regenerative medicine (RM) have attracted significant public attention worldwide. Simultaneously, scientific communities and science policies have tried to establish appropriate governance of SCR and RM. In this context, effective communication between scientific communities and the public is regarded as a key factor. However, the diversity of public attitudes and interests has not been sufficiently examined, especially the differences across countries. Methods: We conducted an international comparison of public attitudes toward SCR and RM. We circulated an internet questionnaire among people in six countries: Japan, South Korea, the United States, the UK, Germany, and France. We collected 100 valid responses from each country, and a total of 600 responses were obtained. Results: Our key findings are the diversity of interests in RM, which can be expressed as user pragmatism, governance and handling of RM, risk, and benefit, and scientific interests. The priority of interests varied across the six countries, and the variations may be influenced by the political, social, cultural, and media contexts of SCR and RM in each country. Conclusion: The implications can contribute to a deeper understanding of the diversity of public attitudes, and bring about an appropriate examination of a wide range of ethical and social concerns of SCR and RM in global contexts.
  • 八代嘉美, 標葉隆馬, 井上悠輔, 一家綱邦, 岸本充生, 東島仁
    科学技術社会論研究 (18) 137-146 2020年4月  招待有り
  • Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K
    Physiological reviews 99(1) 79-114 2019年1月  査読有り
  • Ludwig TE, Kujak A, Rauti A, Andrzejewski S, Langbehn S, Mayfield J, Fuller J, Yashiro Y, Hara Y, Bhattacharyya A
    Cell stem cell 23(5) 644-648 2018年11月  査読有り
  • Ryuma Shineha, Yusuke Inoue, Tsunakuni Ikka, Atsuo Kishimoto, Yoshimi Yashiro
    Stem Cells Translational Medicine 7(2) 251-257 2018年2月1日  査読有り
    Owing to the rapid progress in stem cell research (SCR) and regenerative medicine (RM), society's expectation and interest in these fields are increasing. For effective communication on issues concerning SCR and RM, surveys for understanding the interests of stakeholders is essential. For this purpose, we conducted a large-scale survey with 2,160 public responses and 1,115 responses from the member of the Japanese Society for Regenerative Medicine. Results showed that the public is more interested in the post-realization aspects of RM, such as cost of care, countermeasures for risks and accidents, and clarification of responsibility and liability, than in the scientific aspects the latter is of greater interest only to scientists. Our data indicate that an increased awareness about RM-associated social responsibility and regulatory framework is required among scientists, such as those regarding its benefits, potential accidents, abuse, and other social consequences. Awareness regarding the importance of communication and education for scientists are critical to bridge the gaps in the interests of the public and scientists. Stem Cells Translational Medicine 2018 7:251–257.
  • Ryuma Shineha, Yusuke Inoue, Tsunakuni Ikka, Atsuo Kishimoto, Yoshimi Yashiro
    REGENERATIVE THERAPY 7 89-97 2017年12月  査読有り
    It is essential to understand the hurdles, motivation, and other issues affecting scientists' active participation in science communication to bridge the gap between science and society. This study analyzed 1115 responses of Japanese scientists regarding their attitudes toward science communication through a questionnaire focusing on the field of stem cell and regenerative medicine. As a result, we found that scientists face systemic issues such as lack of funding, time, opportunities, and evaluation systems for science communication. At the same time, there is a disparity of attitudes toward media discourse between scientists and the public. (C) 2017, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
  • 標葉隆馬, 井上悠輔, 八代嘉美
    成城文藝 240 398-416 2017年6月  査読有り
  • Arisa Ema, Hirotaka Osawa, Hiromitsu Hattori, Naonori Akiya, Nobutsugu Kanzaki, Ryutaro Ichise, Minao Kukita, Takushi Otani, Akinori Kubo, Kazunori Komatani, Reina Saijo, Mikihito Tanaka, Koziro Honda, Naoki Miyano, Yoshimi Yashiro, Go Yoshizawa
    Proceedings of the 2017 CHI Conference on Human Factors in Computing Systems, Denver, CO, USA, May 06-11, 2017, Extended Abstracts. 837-847 2017年  査読有り
  • Kenji Ishihara, Asuka Ichinomiya, Mami Inami, Tomomi Hashimoto, Rie Yuzawa, Miari Ishizu, Toshie Hirohara, Yoshimi Yashiro, Toshiyuki Takizawa
    REGENERATIVE THERAPY 5 96-106 2016年12月  査読有り
    We studied the recognition of, interest in, and understanding of induced pluripotent stem (iPS) cells and regenerative medicine in a total of 2659 junior high school, senior high school, and university students. The number of valid responses received was 2396 (90.1%). We report the following seven observations [1]. More than 80% of students reported recognition of iPS cells, regenerative medicine, and Professor Shinya Yamanaka, and a similar number were interested in and supportive of regenerative medicine [2]. Regenerative medicine was viewed as a medical treatment option. However, females were more cautious regarding use of regenerative medicine as a treatment compared with males [3]. Approximately 90% of students were interested in the latest medical care. Among the new treatment methods, they more frequently selected those that they were more familiar with and perceived less invasive to be ideal [4]. Regarding organ or tissue donation in regenerative medicine, students focused more on the characteristics of the donors [5]. Approximately 90% were supportive of storing their own cells. However, approximately 50% of students supported storing iPS cells for use in regenerative medicine [6]. Most students were anxious regarding the side effects, safety, and treatment costs of regenerative medicine, but supported the need of education regarding regenerative medicine [7]. More than 70% of students thought that education of regenerative medicine was necessary for the public. These findings suggest the importance of social approach, in addition to medical approach such as research and development, to improve QOL in community by developing the public understanding of regenerative medicine through science communication and school education, for the establishment of systems to promote this field. (C) 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
  • Arisa Ema, Naonori Akiya, Hirotaka Osawa, Hiromitsu Hattori, Shinya Oie, Ryutaro Ichise, Nobutsugu Kanzaki, Minao Kukita, Reina Saijo, Otani Takushi, Naoki Miyano, Yoshimi Yashiro
    IEEE TECHNOLOGY AND SOCIETY MAGAZINE 35(4) 68-75 2016年12月  査読有り
  • Yusuke Inoue, Ryuma Shineha, Yoshimi Yashiro
    CELL STEM CELL 19(2) 152-153 2016年8月  査読有り
  • Tsunakuni Ikka, Misao Fujita, Yoshimi Yashiro, Hiroshi Ikegaya
    CELL STEM CELL 17(6) 767 2015年12月  査読有り
  • Tsunakuni Ikka, Misao Fujita, Yoshimi Yashiro, Hiroshi Ikegaya
    CELL STEM CELL 17(5) 507-508 2015年11月  査読有り
  • Yashiro Y
    Nihon rinsho. Japanese journal of clinical medicine 73 Suppl 5 537-543 2015年6月  査読有り
  • Misao Fujita, Yoshimi Yashiro, Mika Suzuki
    JOURNAL OF MEDICAL ETHICS 40(11) 735-736 2014年11月  査読有り
    Sparrow highlights three potential applications of in vitro eugenics, that is, (a) research into the heredity of genetic disorders, b) production of cell lines with specific genotypes, and (c) breeding better babies, and points to the need for researchers to discuss in advance the potential ethical problems that may emerge if the realization of this technology occurs in the near future. In this commentary, we pose a question for the sake of discussion. Is it, in fact, appropriate to label all three applications raised by Sparrow as eugenics? By doing so, an unnecessary level of concern might be borne among the public, and as a result, the sound development of this specialized technology would be affected. If the label of eugenics is to be applied to all three of these applications, then Sparrow must justify how he perceives (a) and (b) as not inherently different from (c).
  • Yoshimi Yashiro, Hideo Bannai, Takashi Minowa, Tomohide Yabiku, Satoru Miyano, Mitsujiro Osawa, Atsushi Iwama, Hiromitsu Nakauchi
    INTERNATIONAL JOURNAL OF HEMATOLOGY 89(1) 24-33 2009年1月  査読有り
    Microarray analysis has made it feasible to carry out extensive gene expression profiling in a single assay. Various hematopoietic stem cell (HSC) populations have been subjected to microarray analyses and their profiles of gene expression have been reported. However, this approach is not suitable to identify novel transcripts or for profiling of genes with low expression levels. To obtain a detailed gene expression profile of CD34(-)c-Kit(+)Sca-1(+)lineage marker-negative (Lin(-)) (CD34(-)KSL) HSCs, we constructed a CD34(-)KSL cDNA library, performed high-throughput sequencing, and compared the generated profile with that of another HSC fraction, side population (SP) Lin(-) (SP Lin(-)) cells. Sequencing of the 5'-termini of about 9,500 cDNAs from each HSC library identified 1,424 and 2,078 different genes from the CD34(-)KSL and SP Lin(-) libraries, respectively. To exclude ubiquitously expressed genes including housekeeping genes, digital subtraction was successfully performed against EST databases of other organs, leaving 25 HSC-specific genes including five novel genes. Among 4,450 transcripts from the CD34(-)KSL cDNA library that showed no homology to the presumable protein-coding genes, 29 were identified as strong candidates for mRNA-like non-coding RNAs by in silico analyses. Our cyclopedic approaches may contribute to understanding of novel molecular aspects of HSC function.

MISC

 98
  • 八代 嘉美
    医学のあゆみ 276(6) 668-672 2021年2月  
    近年、オルガノイドが大きな注目を集めている。武部は、その起源を細胞生物学の萌芽期にWilsonが報告したカイメンの細胞凝集に求めているが、事実"形態形成"という生命誌における大きなトピックスは常に生命科学の進歩とともにある。すなわち、研究対象の中枢に置くか否かは別として、オルガノイドという概念は生命科学に携わる人間にとって常に関心事項であったことは間違いない。しかし、その注目が高まるようになった契機は、武部がオルガノイド3.0期と称する時期、すなわちヒトES細胞、iPS細胞といった多能性幹細胞の成立とその操作可能性を得られたこの20年のことであり、さらにこの数年は、その視線は加熱している。それは、生命科学研究者といった、科学的な見地からオルガノイドに関心を持つこれまでのプレイヤーだけでなく、倫理的・法的・社会的問題(ELSI)の観点からの新たな熱源が加わったことによる。では、その新たな視線のなかで、生命科学の現場は何を考え、どうするべきであろうか。本稿では、オルガノイド研究が基礎科学的にも実学的にも多くの実りを得るために、われわれが考えておくべきことを整理したい。(著者抄録)
  • 八代 嘉美
    公衆衛生 84(10) 681-686 2020年10月  
    <文献概要>はじめに 本誌の読者諸賢は,「再生医療」という言葉にどういうイメージをお持ちだろうか.表1は,現在薬価承認を受けている再生医療等製品の一覧である(遺伝子治療を除く).日本で「再生医療等製品」と呼ばれるカテゴリーの製品は,世界的にも開発競争が加速しており,世界では約260件の治験が進行している.だが,それらは一般的に想像される「再生医療」とどの程度一致するものだろうか.本稿では再生医療について基礎的な知識を解説しつつ,現状と展望について解説する.
  • 八代 嘉美
    日本難病医療ネットワーク学会機関誌 7(1) 77-77 2019年11月  
  • 八代 嘉美
    思想 (1141) 97-106 2019年5月  
  • 八代 嘉美
    現代思想 47(6) 60-63 2019年5月  

書籍等出版物

 18

講演・口頭発表等

 7

共同研究・競争的資金等の研究課題

 8

その他

 2
  • TBSラジオ Session-22など出演多数。
  • NHL「ニュース深掘り」、「サイエンスゼロ」、YTV「ミヤネ屋」など出演多数。